HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?

Abstract
In Guadeloupe, there is an abnormally high frequency of atypical parkinsonism. Only one-third of the patients that develop parkinsonian symptoms were reported to present the classical features of idiopathic Parkinson disease and one-third a syndrome resembling progressive supranuclear palsy (PSP). The others were unclassifiable, according to established criteria. We carried out a cross-sectional study of 160 parkinsonian patients to: (i) define more precisely the clinical phenotypes of the PSP-like syndrome and the parkinsonism that was considered unclassifiable in comparison with previously known disorders; (ii) define the neuropsychological and brain imaging features of these patients; (iii) evaluate to what extent a candidate aetiological factor, the mitochondrial complex I inhibitor annonacin contained in the fruit and leaves of the tropical plant Annona muricata (soursop) plays a role in the neurological syndrome. Neuropsychological tests and MRI were used to classify the patients into those with Parkinson's disease (31%), Guadeloupean PSP-like syndrome (32%), Guadeloupean parkinsonism-dementia complex (PDC, 31%) and other parkinsonism-related disorders (6%). Patients with a PSP-like syndrome developed levodopa-resistant parkinsonism, associated with early postural instability and supranuclear oculomotor dysfunction. They differed, however, from classical PSP patients by the frequency of tremor (>50%), dysautonomia (50%) and the occurrence of hallucinations (59%). PDC patients had levodopa-resistant parkinsonism associated with frontosubcortical dementia, 52% of these patients had hallucinations, but, importantly, none had oculomotor dysfunction. The pattern of neuropsychological deficits was similar in both subgroups. Cerebral atrophy was seen in the majority of the PSP-like and PDC patients, with enlargement of the third ventricle and marked T2-hypointensity in the basal ganglia, particularly the substantia nigra. Consumption of soursop was significantly greater in both PSP-like and PDC patients than in controls and Parkinson's disease patients. In conclusion, atypical Guadeloupean parkinsonism comprises two forms of parkinsonism and dementia that differ clinically by the presence of oculomotor signs, but have similar cognitive profiles and neuroimaging features, suggesting that they may constitute a single disease entity, and both were similarly exposed to annonaceous neurotoxins, notably annonacin.
AuthorsAnnie Lannuzel, G U Höglinger, S Verhaeghe, L Gire, S Belson, M Escobar-Khondiker, P Poullain, W H Oertel, E C Hirsch, B Dubois, M Ruberg
JournalBrain : a journal of neurology (Brain) Vol. 130 Issue Pt 3 Pg. 816-27 (Mar 2007) ISSN: 1460-2156 [Electronic] England
PMID17303592 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Age of Onset
  • Aged
  • Annonaceae
  • Brain (pathology)
  • Cross-Sectional Studies
  • Dementia (diagnosis, epidemiology, pathology)
  • Diet
  • Female
  • Fruit
  • Guadeloupe (epidemiology)
  • Humans
  • Magnetic Resonance Imaging (methods)
  • Male
  • Neuropsychological Tests
  • Parkinson Disease (diagnosis, epidemiology, pathology)
  • Parkinsonian Disorders (diagnosis, epidemiology, pathology)
  • Phenotype
  • Plant Leaves
  • Prospective Studies
  • Risk Factors
  • Supranuclear Palsy, Progressive (diagnosis, epidemiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: